AB036. Comparison of the effectiveness of gefitinib, erlotinib and afatinib in epidermal growth factor receptor mutated tumors of non-small cell lung cancer

The non-small cell lung cancer (NSCLC) accounts approximately 85% of lung cancers and includes predominantly adenocarcinomas, which is the most common type and squamous cell carcinomas. The treatment options include surgery, radiation therapy, and chemotherapy and the decision depends on the patient...

Full description

Saved in:
Bibliographic Details
Published in:Ann Transl Med
Main Authors: Papathanasiou, Maria, Lambaki, Sofia, Porpodis, Konstantinos, Spyratos, Dionysios, Tryfon, Stayros, Zarogoulidis, Paulos, Eleytheriadoy, Ellada, Kontakiotis, Theodoros
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2016
Subjects:
Abstract
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159369/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB036
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items